Secretome Analysis of Cardiomyocytes Identifies PCSK6 (Proprotein Convertase Subtilisin/Kexin Type 6) as a Novel Player in Cardiac Remodeling After Myocardial Infarction.

Abstract

BACKGROUND:

Acute occlusion of a coronary artery results in swift tissue necrosis. Bordering areas of the infarcted myocardium can also experience impaired blood supply and reduced oxygen delivery, leading to altered metabolic and mechanical processes. Although transcriptional changes in hypoxic cardiomyocytes are well studied, little is known about the proteins that are actively secreted from these cells.

METHODS:

We established a novel secretome analysis of cardiomyocytes by combining stable isotope labeling and click chemistry with subsequent mass spectrometry analysis. Further functional validation experiments included ELISA measurement of human samples, murine left anterior descending coronary artery ligation, and adeno-associated virus 9-mediated in vivo overexpression in mice.

RESULTS:

The presented approach is feasible for analysis of the secretome of primary cardiomyocytes without serum starvation. A total of 1026 proteins were identified to be secreted within 24 hours, indicating a 5-fold increase in detection compared with former approaches. Among them, a variety of proteins have not yet been explored in the context of cardiovascular pathologies. One of the secreted factors most strongly upregulated upon hypoxia was PCSK6 (proprotein convertase subtilisin/kexin type 6). Validation experiments revealed an increase of PCSK6 on mRNA and protein level in hypoxic cardiomyocytes. PCSK6 expression was elevated in hearts of mice after 3 days of ligation of the left anterior descending artery, a finding confirmed by immunohistochemistry. ELISA measurements in human serum also indicate distinct kinetics for PCSK6 in patients with acute myocardial infarction, with a peak on postinfarction day 3. Transfer of PCSK6-depleted cardiomyocyte secretome resulted in decreased expression of collagen I and III in fibroblasts compared with control treated cells, and small interfering RNA-mediated knockdown of PCSK6 in cardiomyocytes impacted transforming growth factor-β activation and SMAD3 (mothers against decapentaplegic homolog 3) translocation in fibroblasts. An adeno-associated virus 9-mediated, cardiomyocyte-specific overexpression of PCSK6 in mice resulted in increased collagen expression and cardiac fibrosis, as well as decreased left ventricular function, after myocardial infarction.

CONCLUSIONS:

A novel mass spectrometry-based approach allows investigation of the secretome of primary cardiomyocytes. Analysis of hypoxia-induced secretion led to the identification of PCSK6 as being crucially involved in cardiac remodeling after acute myocardial infarction.

• Authors: Tim Christian Kuhn, Johannes Knobel, Sonja Burkert-Rettenmaier, Xue Li, Ingmar Sören Meyer, Andreas Jungmann, Florian Sicklinger, Johannes Backs, Felix Lasitschka, Oliver J Müller, Hugo A Katus, Jeroen Krijgsveld, Florian Leuschner
• Journal: Circulation (Circulation) Vol. 141 Issue 20 Pg. 1628-1644 (05 19 2020) ISSN: 1524-4539 [Electronic] United States
• PMID: 32100557 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Proteome
• PCSK9 protein, human
• PCSK9 protein, rat
• Pcsk9 protein, mouse
• Proprotein Convertase 9

Topics

• Animals
• Animals, Newborn
• Cells, Cultured
• Disease Models, Animal
• Humans
• Male
• Mice, Inbred C57BL
• Myocardial Infarction (enzymology, genetics, pathology, physiopathology)
• Myocytes, Cardiac (enzymology, pathology)
• Proprotein Convertase 9 (genetics, metabolism)
• Proteome
• Rats, Wistar
• Secretory Pathway
• Signal Transduction
• Ventricular Function, Left
• Ventricular Remodeling